. Author manuscript; available in PMC: 2022 Jan 14.

Published in final edited form as: J Acquir Immune Defic Syndr. 2022 Feb 1;89(2):222–230. doi: 10.1097/QAI.0000000000002847

Table 3.

Prevalence and association of sleep quality as measured by the Pittsburgh Sleep Quality Index by mental health symptom burden. (n=1583)

Measures	Poor sleep PSQI >5 (n=821)	Better sleep PSQI ≤5 (n=762)	p value	Unadjusted OR (95% CI)	Adjusted^a OR (95% CI)

	n (%)	n (%)
High depressive symptoms
Yes, CES-D ≥16	383 (46.7)	98 (12.9)	<0.0001	5.92 (4.60-7.63)^*	5.06 (3.87-6.63)^*
No, CES-D <16	438 (53.3)	664 (87.1)		Ref.	Ref.
High anxiety symptoms
Yes, GAD-7 ≥10	252 (30.7)	50 (6.6)	<0.0001	6.31 (4.57-8.71)^*	5.70 (4.05-8.02)^*
No, GAD-7 <10	569 (69.3)	712 (93.4)		Ref.	Ref.

Significant at p<0.0001

Adjusted for HIV disease status, age in years, race, education, employment, BMI, smoking, drinking, non-injection and injection drug use, menopausal status, and WIHS site